BURNSIDE WILLIAM H.L. 4
4 · AbbVie Inc. · Filed May 12, 2026
Research Summary
AI-generated summary of this filing
AbbVie (ABBV) Director William Burnside Receives RSU Award
What Happened
William H.L. Burnside, a director of AbbVie Inc. (ABBV), was granted 1,118 restricted stock units (RSUs) on May 8, 2026. The Form 4 reports the acquisition as an award (transaction code A) with a reported acquisition value of $0 (no cash paid). This is a grant of equity compensation, not an open‑market purchase or sale.
Key Details
- Transaction date: 2026-05-08 (reported on Form 4 filed 2026-05-12). Filing appears timely.
- Transaction type/code: Award (A) — restricted stock units (RSUs).
- Shares/units granted: 1,118 RSUs; reported acquisition value $0.
- Shares owned after transaction: Not specified in the provided filing.
- Footnote: RSUs awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program. They will be paid one-for-one in AbbVie common shares on the earlier of the director’s separation from service, death, or a change in control (as defined in the Program).
Context
RSU grants are a form of compensation and do not reflect an immediate cash investment or sale by the insider. They convert into common shares only upon the vesting/payment events described in the footnote (separation, death, or change in control). For retail investors, awards signal how a company compensates directors but are not the same signal as an insider buying shares on the open market.
Insider Transaction Report
- Award
Common Stock, $0.01 par value
[F1]2026-05-08+1,118→ 28,076 total
Footnotes (1)
- [F1]These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).